Prevalence of psychoactive substances, alcohol, illicit drugs, and medicines, in Spanish drivers: A roadside study

Gomez-Talegon, M. Trinidad; Fierro, Inmaculada; Gonzalez-Luque, Juan Carlos; Colás, Mónica; López-Rivadulla, Manuel; Álvarez, F. Javier

doi:10.1016/j.forsciint.2012.08.012

Cited by 41 publications

(34 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Results from the 2015 survey are presented with the same format as used in the 2008 and 2013 survey publications [3], [4] which were already reported after applying weights to balance for overall intensity of traffic flow.…”

Section: Resultsmentioning

confidence: 99%

“…Spain, 2008, 2013 and 2015.DRUID-2008a n =3302DRUID-2013b n =2932EDAP-2015 n =2744 n % (95% CI) n % (95% CI) n % (95% CI)Tested negative (−) for alcohol or drugs276383.7 (82.4–84.9)257887.9 (86.7–89.1)240687.7 (86.5–88.9)Tested positive (+) for alcohol or drugs53916.3 (15.1–17.6)35412.1 (10.9–13.3)33912.3 (11.1–13.6)+ alcohol/− drugs1514.6 (3.9–5.3)973.30 (2.7–3.9)331.2 (0.8–1.6)− alcohol/+ drugs3219.7 (8.7–10.7)2338.0 (7.0–8.9)29310.7 (9.5–11.8)+ alcohol/+ drugs672.0 (1.5–2.5)240.8 (0.5–1.1)130.5 (0.2–0.7)a[3].b[4].…”

Section: Resultsmentioning

confidence: 99%

“…Detailed information about sample planning (considering both geographical and temporal aspects), driving recruitment, data collection and toxicological aspects can be found elsewhere [1], [3], [4]. Data obtained at the roadside with commercial screening instruments in 2015, after weighting, is presented.…”

Section: Methodsmentioning

confidence: 99%

See 2 more Smart Citations

Data from roadside screening for psychoactive substances, alcohol and illicit drugs, among Spanish drivers in 2015

Herrero¹,

Domingo‐Salvany²,

Torre³

2017

Data in Brief

View full text Add to dashboard Cite

The data presented in this article are related to the paper “Prevalence of psychoactive substances, alcohol and illicit drugs, in Spanish drivers: A roadside study in 2015”. (https://doi.org/10.1016/j.forsciint.2017.07.005) Domingo-(Salvany et al., 2017) [1]. In that paper it was not possible to directly compare 2015 results with previous editions for various reasons, one of which was the lack of a similar weighting procedure. The present paper provides 2015 figures of roadside screening tests which are weighted for traffic flow intensity and therefore allow direct comparisons with the screening tests conducted among Spanish drivers in 2008 and 2013.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Data from roadside screening for psychoactive substances, alcohol and illicit drugs, among Spanish drivers in 2015

Herrero¹,

Domingo‐Salvany²,

Torre³

2017

Data in Brief

View full text Add to dashboard Cite

show abstract

“…18 On reexamining the data according to traffic distribution in Spain and including information referred to motorcycles, the percentage of positive cases for such substances was found to be 16.9%. 19 The aggravating factor of recidivism also must be added to the above considerations. Indeed, in cases of trauma associated to alcohol and drugs, the probability of recidivism doubles in comparison with trauma cases not related to such substances.…”

Section: Palabras Clavementioning

confidence: 99%

Challenges in care of trauma patient in Spain. The need for implementation of scientific evidence including secondary prevention

Mondéjar

Álvarez

Luque

2014

Medicina Intensiva (English Edition)

View full text Add to dashboard Cite

The mortality of trauma patients has improved significantly in recent decades due to a combination of factors: medical care, educational campaigns and structural changes. Generalization of both out-of hospital emergence medical services and the hospital care in specific centers for traumatized has undoubtedly contributed to this decline, but other factors such as periodic campaigns to prevent workplace and traffic accidents, as well as improvements in the road network have played a key role.The challenge now is to contain mortality, for which is essential an analysis of the situation to detect potential areas of improvement.The application of diagnostic or therapeutic actions with scientific evidence is associated with lower mortality, but as in other areas of medicine, the application of scientific evidence in trauma patients is barely 50%. Moreover, nearly 90% of trauma deaths occur in the crash site or during the first 72 h of hospitalization, the vast majority as a result of injuries incompatible with life. In these circumstances it is clear that prevention is the most cost-effective activity. As medical practitioners, our role in prevention is mainly focused on the secondary prevention to avoid recidivism, for which it is necessary to identify the possible risk factors (frequently alcohol, illegal drugs, psychotropic medication, etc.) and implement a brief motivational intervention. This activity can reduce recidivism by nearly 50%. In Spain, the activity in this field is negligible; therefore, measures should be implemented for dissemination of secondary prevention in trauma.

show abstract

“…In 2012, our team published data on drivers tested at random, showing a proportion of benzodiazepine users of 1.6% among all who had a positive result (Gómez-Talegón et al, 2012). Figures may be disquieting considering that proportion of positives may be higher among impaired drivers, as shown by other European study (Bezemer et al, 2014).…”

Section: Introductionmentioning

confidence: 99%

The Problem of Benzodiazepine Use and Its Extent in the Driver Population: A Population-Based Registry Study

et al. 2018

View full text Add to dashboard Cite

Background: Benzodiazepines are driving-impairing medicines (DIM). This study presents current consumption of dispensed benzodiazepines in the Spanish general population, with a focus in pattern of use and concomitant medicines consumed with.Methods: A population-based registry study was carried out to assess the year-2016 granted benzodiazepines dispensation in Castile and León. Weighting was performed to obtain the adjusted benzodiazepine consumption for licensed drivers according to age and gender using our national drivers' license census data.Results: Benzodiazepines were used by 15.38% of the general population and 10.97% of drivers. Nearly 2% of the population and more than 1% of drivers took these medicines every day. The amount consumed (until 3 or more benzodiazepines per day) and concomitant use of other DIM were also higher. Women were the most frequent consumers, and anxiolytic use was usual. Consumption increases with age, but there were differences between men and women drivers from 60 years old.Conclusions: The current use of benzodiazepines must serve to awareness of the healthcare personnel, patients, and authorities on their risks, above all on the road safety.

show abstract

Prevalence of psychoactive substances, alcohol, illicit drugs, and medicines, in Spanish drivers: A roadside study

Cited by 41 publications

References 14 publications

Data from roadside screening for psychoactive substances, alcohol and illicit drugs, among Spanish drivers in 2015

Data from roadside screening for psychoactive substances, alcohol and illicit drugs, among Spanish drivers in 2015

Challenges in care of trauma patient in Spain. The need for implementation of scientific evidence including secondary prevention

The Problem of Benzodiazepine Use and Its Extent in the Driver Population: A Population-Based Registry Study

Contact Info

Product

Resources

About